ChartGenie

4:1 R2R trading opportunity

NASDAQ:EYPT   EyePoint Pharmaceuticals, Inc.
Prices taking support on an upward trend line. Fibonacci and previous major resistance levels support a likely 4:1 trading opportunity.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。